Complement component 5 deficiency
|
0.610 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Asthma
|
0.230 |
GeneticVariation
|
disease |
BEFREE |
To determine whether genetic variations in the genes of the complement system affect susceptibility to BA, we screened single nucleotide polymorphisms (SNPs) in C3, C5, the C3a receptor gene (C3AR1), and the C5a receptor gene (C5R1) and performed association studies in the Japanese population.
|
15278436 |
2004 |
Rheumatoid Arthritis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Recent studies have shown that genetic variants on the TRAF1/C5 (tumor necrosis factor receptor-associated factor 1, complement component 5) locus confer susceptibility to rheumatoid arthritis (RA).
|
20030635 |
2010 |
Rheumatoid Arthritis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
Replication of the tumor necrosis factor receptor-associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study.
|
18759306 |
2008 |
Rheumatoid Arthritis
|
0.160 |
GeneticVariation
|
disease |
GWASDB |
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
|
19503088 |
2009 |
Rheumatoid Arthritis
|
0.160 |
GeneticVariation
|
disease |
BEFREE |
To determine whether the tumor necrosis factor (TNF)-receptor associated factor 1/complement component 5 (TRAF1/C5) polymorphism (rs10818488) confers susceptibility to rheumatoid arthritis (RA) and systemic lupus erythematous (SLE), a meta-analysis was performed.
|
23321589 |
2013 |
Rheumatoid Arthritis
|
0.160 |
GeneticVariation
|
disease |
LHGDN |
A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
|
17880261 |
2007 |
Rheumatoid Arthritis
|
0.160 |
GeneticVariation
|
disease |
GWASDB |
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
|
17804836 |
2007 |
Rheumatoid Arthritis
|
0.160 |
GeneticVariation
|
disease |
LHGDN |
Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis.
|
19116907 |
2009 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.
|
29212778 |
2018 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
ECULIZUMAB, POOR RESPONSE TO
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Familial Mediterranean Fever
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Investigation of C5a receptor gene 450 C/T polymorphism in Turkish patients with familial Mediterranean fever.
|
19657723 |
2010 |
Arthus Reaction
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The in vivo efficacy was evaluated in three different animal models of immune complex diseases in mice, i.e., the reverse passive Arthus reaction in the peritoneum, skin, and lung.The i.v. application of the C5a receptor antagonist abrogated polymorphonuclear neutrophil accumulation in peritoneum and markedly attenuated polymorphonuclear neutrophil migration into the skin and the lung.
|
10395696 |
1999 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association of Complement C5 Gene Polymorphisms with Proliferative Diabetic Retinopathy of Type 2 Diabetes in a Chinese Han Population.
|
26934706 |
2016 |
Failure to Thrive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The defect in Leiner's disease, which presents in early infancy with extensive dermatitis, diarrhoea, and failure to thrive, has been attributed to a defect of the fifth component of complement (C5).
|
144462 |
1977 |
Meningococcal meningitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Absence of the fifth component of complement (C5) by immunochemical assay and marked deficiency by hemolytic assay (less than 0.1%) was found in a family in which the oldest male child had suffered severe and recurrent meningococcemia at age 15 years, two brothers developed meningococcal meningitis four years later (at ages 18 and 14 years), and a sister had the gonococcal arthritis-dermatitis syndrome.
|
6785713 |
1981 |
Neoplasm Metastasis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Mice lacking a functional gene for complement C5 had smaller primary tumors, which were less invasive and lacked the CD68+ macrophages that have previously been associated with metastasis in this type of tumor.
|
27105526 |
2016 |
Periodontitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The tagging SNP rs17611 of the C5 gene and smoking may be associated with periodontitis among the Hong Kong Chinese population.
|
19909405 |
2010 |
Rheumatic Heart Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We observed no association with RHD for the five tagging single nucleotide polymorphisms (tSNP) in the C5 gene, the three tSNPs in the TNFAIP3 gene, or the two tSNPs in the TRAF1 gene.
|
19902201 |
2009 |
Virus Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Small molecule inhibitors of the C5a receptor had antifibrotic effects in vivo, and common haplotype-tagging polymorphisms of the human gene C5 were associated with advanced fibrosis in chronic hepatitis C virus infection.
|
15995705 |
2005 |
Proliferative diabetic retinopathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Association of Complement C5 Gene Polymorphisms with Proliferative Diabetic Retinopathy of Type 2 Diabetes in a Chinese Han Population.
|
26934706 |
2016 |
Tumor Progression
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Genetic deletion of C3 or the C5a receptor 1 (C5aR1), and pharmacological blockade of C5aR1, impaired the ability of T cells to overcome the endothelial barrier, infiltrate tumors, and control tumor progression <i>in vivo</i>, while genetic chimera mice demonstrated that C3 and C5aR1 expression by tumor stroma, and not leukocytes, governs T cell homing, acting on the local endothelium.
|
28932632 |
2017 |
Ischemic stroke
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We used a case-control study involving 386 IS patients and 386 non-IS controls from a rural population and determined the genotypes of five polymorphisms (rs12237774, rs17611, rs4837805, rs7026551, and rs1017119) of C5 gene by Snapshot single-nucleotide polymorphism genotyping assays to assess any links with IS.
|
27768391 |
2016 |